[Malignant struma ovarii: a case report]

J Gynecol Obstet Biol Reprod (Paris). 2005 Dec;34(8):815-8. doi: 10.1016/s0368-2315(05)82960-6.
[Article in French]

Abstract

Malignant transformation of struma ovarii is exceptional (less than 1%). The histolological diagnosis of malignancy is difficult especially in the well differentiated forms. Immunohistochemistry is highly contributive in the anaplastic forms. The prognosis is relatively favorable except for the metastatic and undifferentiated forms. We report a case of malignant struma ovarii with metastasis observed in a 65-year-old woman who died rapidly from her disease. In light of this observation, we discuss the diagnositic, management and outcome features of these particular tumors.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Aged
  • Antineoplastic Agents / therapeutic use
  • Fatal Outcome
  • Female
  • Humans
  • Immunohistochemistry
  • Keratin-7
  • Keratins / analysis
  • Neoplasm Metastasis
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / pathology
  • Ovarian Neoplasms / therapy
  • Radiotherapy
  • Struma Ovarii / diagnosis*
  • Struma Ovarii / pathology
  • Struma Ovarii / therapy
  • Thyroglobulin / analysis

Substances

  • Antineoplastic Agents
  • KRT7 protein, human
  • Keratin-7
  • Keratins
  • Thyroglobulin